Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    7683111 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Trastuzumab, Docetaxel;   Drug: Trastuzumab, Docetaxel, Bevacizumab;   Drug: Trastuzumab+Docetaxel+NPLD;   Drug: Trastuzumab+Docetaxel+NPLD+Bevacizumab
2 Active, not recruiting Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation
Condition: Cancer of the Breast
Interventions: Procedure: Surgery for breast cancer;   Other: No Loco-regional treatment
3 Recruiting Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Capecitabine;   Drug: Bevacizumab;   Drug: Oxaliplatin;   Drug: Irinotecan
4 Recruiting Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer
Conditions: Synchronous Metastasized Breast Cancer;   Circulating Tumor Cells
Interventions: Procedure: Surgery;   Procedure: Surgery on Demand

Indicates status has not been verified in more than two years